首页|细胞因子IL-6和TNF-α在乳腺癌新辅助治疗中应用价值

细胞因子IL-6和TNF-α在乳腺癌新辅助治疗中应用价值

扫码查看
目的 分析细胞因子白介素-6(interleukin-6,IL-6)、肿瘤坏死因子-α(tumor necrosis factor α,TNF-α)的表达水平与乳腺癌病理特征及新辅助治疗(neoadjuvant therapy,NAT)疗效的相关性。方法 回顾性选取2022年到2023年金华市人民医院收治41例乳腺癌患者为观察组,随机选取41例体检女性为对照组。分析两组血清标本中IL-6、TNF-α水平与病理特征的相关性;观察NAT前后IL-6和TNF-α变化与NAT疗效相关性。结果 观察组NAT前IL-6、TNF-α表达水平与肿瘤大小、临床分期有相关性。IL-6、TNF-α变化水平与NAT彩超评估有效组、病理学评估有效组有相关性。结论 IL-6、TNF-α动态检测可以在一定程度下反应乳腺癌患者NAT疗效。
Cytokines IL-6 and TNF-α the Value of Neoadjuvant Therapy in Breast Cancer
Objective To analyze the relationship between the expression levels of cytokines IL-6 and TNF-α and the pathological char-acteristics of breast cancer and the efficacy of neoadjuvant therapy.Methods 41 patients with breast cancer admitted to Jinhua People's Hospital from 2022 to 2023(observation group)were retrospectively selected,and 41 women for physical examination(control group)were randomly selected.Analyze the correlation between IL-6,TNF-α levels and pathological features in two sets of serum samples;Ob-serve the correlation between changes in IL-6 and TNF-α before and after neoadjuvant therapy and the efficacy of neoadjuvant therapy.Results The expression levels of IL-6 and TNF-α before neoadjuvant therapy in the observation group were correlated with tumor size and clinical stage.There is a correlation between the levels of IL-6 and TNF-α changes and the effective groups evaluated by neoadju-vant therapy ultrasound and pathological evaluation.Conclusion The dynamic detection of IL-6 and TNF-α can reflect the efficacy of neoadjuvant therapy in breast cancer patients to a certain extent.

breast cancercytokinesneoadjuvant therapyinterleukin-6tumour necrosis factor-α

李洪波、徐月红

展开 >

金华市人民医院乳甲外科,浙江金华 321000

乳腺癌 细胞因子 新辅助治疗 白介素-6 肿瘤坏死因子-α

2024

吉林医药学院学报
吉林医药学院

吉林医药学院学报

影响因子:0.459
ISSN:1673-2995
年,卷(期):2024.45(6)